Posted on by 21b4bddf87157652317827146367558f

Warning: Undefined variable $insensitive in /home/u792129758/domains/sciencefather.com/public_html/cad-conferences/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 201

Warning: Undefined variable $insensitive in /home/u792129758/domains/sciencefather.com/public_html/cad-conferences/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 202

Dr. GLORIA GARCIA-DONAS GABALDON | Hematologist | Best Researcher Award

Dr. GLORIA GARCIA-DONAS GABALDON, Servicio Andaluz de Salud SAS, Spain

Dr. Gloria Garcia-Donas Gabaldon is a medical professional affiliated with the Servicio Andaluz de Salud (SAS) in Spain. With expertise in her field, she is committed to providing high-quality healthcare and improving patient outcomes. Her work reflects a dedication to advancing medical practices and contributing to public health initiatives within the Andalusian healthcare system.

 

Summary:

Dr. Gloria GarcĆ­a-Donas GabaldĆ³n stands out as an exemplary candidate for the Research for Best Researcher Award due to her significant contributions to medical research and public health. Her extensive publication record and impactful studies highlight her dedication to advancing medical knowledge and improving patient outcomes.

 

Professional Profiles:

Google Scholar

šŸŽ“ Education :

Dr. GarcĆ­a-Donas earned her Medical Degree from the University of Seville in 1995, followed by a specialization in Hematology and Hemotherapy in 2001 through the MIR program. She obtained her doctorate in 2008, with a thesis on the prevalence of the G20210A prothrombin mutation in thromboembolic disease, which received a “Cum Laude” distinction. Her academic foundation is reinforced by continuous professional development through numerous accredited courses.

šŸ¢Ā Experience:

Dr. GarcĆ­a-Donas has a diverse professional background, having worked across multiple hospitals in Andalusia, including her current position at Hospital U.V. Macarena in Seville since 2015. Her roles have included responsibilities in laboratory hematimetry and cytomorphology, as well as providing clinical care in various hematological conditions. Over her career, she has accrued significant experience managing anticoagulation therapy and immune thrombocytopenia, focusing on optimizing patient outcomes.

šŸ› ļøSkills:

Gloria GarcĆ­a-Donas GabaldĆ³n is an accomplished hematologist with extensive expertise in hematology, laboratory techniques, and clinical management. She specializes in oral anticoagulation therapy and immune thrombocytopenia, demonstrating proficiency in patient consultations and laboratory responsibilities. Her clinical acumen is complemented by her teaching and research skills, allowing her to effectively communicate complex concepts to peers and students.

Research Focus :

Her research interests center on thromboembolic disorders, immune thrombocytopenia, and hematological malignancies. She has contributed to the scientific community through various publications and presentations, focusing on genetic factors influencing thrombosis, treatment outcomes in hematological conditions, and novel therapeutic approaches in anticoagulation.

šŸ”¬Awards:

Dr. GarcĆ­a-Donas has been recognized for her contributions to hematology, including awards for her research presentations at national and international conferences. Her work has significantly impacted clinical practices and treatment protocols, earning her respect within the medical community for her expertise and commitment to advancing the field of hematology.

 

Conclusion:

In conclusion, Dr. GarcĆ­a-Donas is not only a prolific researcher but also a committed healthcare professional whose work has the potential to influence clinical practices significantly. Recognizing her contributions through the Research for Best Researcher Award would not only honor her achievements but also inspire continued excellence and innovation in the field of medicine.

 

Publications :
  • GarcĆ­a-Donas GabaldĆ³n G. “SĆ­ndromes hemorrĆ”gicos mĆ”s frecuentes en el niƱo.” Pediatr Integral 1998; 3(3): 294-302.
  • GarcĆ­a-Donas GabaldĆ³n G. “Prevalencia de los polimorfismos genĆ©ticos asociados a trombofilia en poblaciĆ³n sana del sur de EspaƱa.” Med Clin (Barc) 2004 Apr 17; 122(14): 556-7.
  • GarcĆ­a-Donas GabaldĆ³n G. “Anemia hemolĆ­tica autoinmune causada por autoanticerpos IgA.” Med Clin (Barc) 2004 Nov 13; 123(17): 678.
  • GarcĆ­a-Donas GabaldĆ³n G. “Aplasia pura de serie roja asociada a leucemia linfoide crĆ³nica con respuesta favorable a rituximab.” Med Clin (Barc) 2005 Nov 19; 125(18): 717-8.
  • GarcĆ­a-Donas GabaldĆ³n G. “The influence of the age in the risk of the prothrombin G20210A mutation for spontaneous venous thrombosis.” Med Clin (Barc) 2007 May 5; 128(17): 652-4.
  • GarcĆ­a-Donas GabaldĆ³n G. “CapĆ­tulo 4.2.4 MPL y mielofibrosis.” In: Manual para el manejo de pacientes con MIELOFIBROSIS. March 2015. ISBN: 978-84-938864-8-6.
  • GarcĆ­a-Donas GabaldĆ³n G. “MIELOFIBROSIS Recomendaciones bĆ”sicas para el diagnĆ³stico, pronĆ³stico y tratamiento.” March 2015. ISBN: 978-84-938864-7-9.
  • GarcĆ­a-Donas GabaldĆ³n G. “Prevalencia de la mutaciĆ³n de la protrombina G20210A en la enfermedad tromboembĆ³lica.” Thesis, May 2008.
  • Villegas A, NĆŗƱez R, Gaya A, Cuevas-Ruiz MV, GarcĆ­a-Donas GabaldĆ³n G. “Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.” Ann Hematol 2017 Oct; 96(10): 1727-1733. doi: 10.1007/s00277-017-3059-x.
  • Matarraz S, Leoz P, FernĆ”ndez C, Colado E, ChillĆ³n MC, GarcĆ­a-Donas GabaldĆ³n G. “Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.” Mod Pathol 2018 Aug; 31(8): 1318-1331. doi: 10.1038/s41379-018-0038-2.
  • Mingot-Castellano ME, GarcĆ­a-Candel F, BenĆ­tez-Hidalgo O, et al. “Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study.” Eur J Haematol 2022 Dec; 109(6): 686-695. doi: 10.1111/ejh.13853.
  • JimĆ©nez-BĆ”rcenas R, GarcĆ­a-Donas GabaldĆ³n G, Campos-Ɓlvarez RM, et al. “Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study.” Br J Haematol 2024 May; 204(5): 1977-1985. doi: 10.1111/bjh.19443.
  • GonzĆ”lez-LĆ³pez TJ, Bermejo-Vega N, Cardesa-Cabrera R, et al. “Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.” Blood 2024 Aug 8; 144(6): 646-656. doi: 10.1182/blood.2024024250.
GLORIA GARCIA-DONAS GABALDON | Hematologist | Best Researcher Award

You May Also Like